All In MedTech

Device Trial Radar · NCT07267741

Using Virtual Reality Technology on Depression, Anxiety, and Stress Among Palestinian Patients Undergoing Breast Biopsy

The Impact of Using Virtual Reality Technology on Depression, Anxiety, and Stress Among Palestinian Patients Undergoing Breast Biopsy: Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

80

Actual

Start

Dec 10, 2025

Primary completion

Jan 10, 2026

Study completion Feb 10, 2026

Sponsor

Lead sponsor
Nablus University for Vocational and Technical EducationAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 5, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this randomized controlled trial was to investigate the impact of Virtual Reality (VR) technology on depression, anxiety, and stress levels among Palestinian patients undergoing breast biopsy. The study aimed to evaluate the effectiveness of VR as a non-pharmacological intervention to reduce psychological distress associated with the biopsy procedure. The main research hypotheses are: H01: There will be no significant difference in depression levels between patients who receive immersive VR during breast biopsy and those who receive standard care. H02: There will be no significant difference in anxiety levels between patients who receive immersive VR during breast biopsy and those who receive standard care. H03: There will be no significant difference in stress levels between patients who receive immersive VR during breast biopsy and those who receive standard care. Participants will: Receive either a VR intervention or standard care during their breast biopsy. Wear a VR headset for 15-30 minutes, experiencing a calming virtual environment designed to promote relaxation. Complete assessments of depression, anxiety, and stress before and after the procedure using validated psychological questionnaires.

Conditions

  • Depression
  • Anxiety
  • Stress

Interventions

  • Meta Quest 2 VR headsetDevice

    The VR intervention will utilize a head-mounted VR headset with built-in headphones. Patients will be selected for VR environments from a predefined list of natural scenes, including a tropical beach, diving, forest, and snowy landscape, each accompanied by relaxing music and nature sounds. The Guided Meditation VR application from Cubicle Ninjas (https://guidedmeditationvr.com/) provides 360-degree immersive nature environments with standardized calming background audio. VR will be applied during the procedure, with sessions lasting 15 to 30 minutes and discontinued if the patient experiences nausea, dizziness, or requests removal.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Depression Anxiety Stress Scale-21 (DASS21)Time frame: before the procedure and then 60 minutes post-procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Rafidia Surgical Governmental Hospital, Nablus City, West Bank, Palestine

    Nablus, West Bank, Palestinian Territories

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.